Related Experiment Video
Updated: May 23, 2026

05:44
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
Prospective randomized controlled study comparing cell block method and conventional smear method for pancreatic
Yutaka Noda1, Naotaka Fujita, Go Kobayashi
1Departments of Gastroenterology Surgery, Sendai City Medical Center, Miyagino-ku, 22-5-1 Tsurugaya, Sendai, Japan. noda@openhp.or.jp
Summary
The cell block (CB) method for pancreatic juice cytology showed fewer borderline malignancies than smear cytology. While overall diagnostic accuracy was similar, CB sensitivity was higher for invasive ductal carcinoma in the pancreatic head.
Area of Science:
- Gastroenterology
- Cytopathology
- Oncology
Background:
- Pancreatic cancer diagnosis often relies on cytological examination of pancreatic juice.
- Conventional smear cytology can yield equivocal results, necessitating improved diagnostic methods.
Purpose of the Study:
- To compare the diagnostic efficacy of the cell block (CB) method versus conventional smear cytology for pancreatic juice.
- To evaluate diagnostic accuracy, sensitivity, and rates of borderline malignancy in pancreatic lesions.
Main Methods:
- A randomized controlled trial involving 170 patients with suspicious pancreatic lesions undergoing ERCP.
- Pancreatic juice was randomized to either the cell block method (n=85) or smear cytology (n=85).
- Cell block sections were stained with H&E, PAS-AB, and IHC; smears used Papanicolaou and Giemsa stains.
Main Results:
- The CB method had a significantly lower rate of borderline malignancy (3.5%) compared to smear cytology (27.1%).
- Overall diagnostic accuracy was comparable (CB: 76.5%, Smear: 74.1%).
- CB sensitivity was superior for invasive ductal carcinoma in the pancreatic head (88.9% vs. 42.9%).
Conclusions:
- The cell block method reduces equivocal borderline malignancy rates in pancreatic juice cytology.
- CB shows a trend towards higher diagnostic yield and improved sensitivity for specific pancreatic cancers.
- Further improvements in sensitivity are needed for widespread application, except for pancreatic head cancer.

